-
4
-
Korean J Hepatol. 2007;13(3):419-422. Published online September 20, 2007.
DOI: https://doi.org/10.3350/kjhep.2007.13.3.419
- A Case of Vasculitis in Chronic Hepatitis C Patient Treated with Pegylated Interferon Alpha-2a and Ribavirin
-
-
- Abstract
- There has been an increase in the number of patients treated with pegylated interferon (PEG-IFN) and ribavirin due to the better antiviral efficacy. The main serious adverse events of PEG-IFN plus ribavirin combination therapy are bone marrow suppression and hemolytic anemia. However, there are few reports of vasculitis occurring during PEG-IFN therapy. We describe a patient who developed vasculitis during the treatment of chronic hepatitis C with PEG-IFN and ribavirin. (Korean J Hepatol 2007;13:419-422)
Keywords :Hepatitis C, chronic; Peginterferon alfa-2a; Vasculitis; Skin
